Literature DB >> 19649691

Naloxone decreases the inhibitory effect of ethanol on the release of arginine-vasopressin induced by physical exercise in man.

Vittorio Coiro1, A Casti, E Volta, A Melani, M L Maffei, P Rubino, P Vacca, G Saccani-Jotti, R Volpi, P Chiodera.   

Abstract

To establish whether ethanol and/or endogenous opioids play a role in the control of arginine-vasopressin (AVP) response to physical exercise, six healthy men underwent six bicycle-ergometer tests until exhaustion [exercise control test; exercise plus ethanol (50 of 110 ml proof whiskey orally), exercise plus naloxone (2 mg injected plus 5 mg infused or 4 mg injected plus 10 mg infused intravenously] or exercise plus ethanol plus naloxone). Plasma AVP levels, physiological and biochemical variables were measured during tests. Physiological and biochemical variables were similar in all tests. During the control test, exercise significantly increased plasma AVP levels, with a peak value five times higher than baseline. The AVP response to exercise was similar in the presence of naloxone, whereas it was abolished by ethanol. When ethanol tests were repeated in the presence of naloxone, at both lower and higher dose, ethanol inhibition on AVP secretion was only partial, with mean peak responses 2.5 times higher than basal values. Results indicate an ethanol involvement in regulation of the AVP response to physical exercise. Furthermore, naloxone-sensitive endogenous opioids appear to play a role in the mechanism underlying ethanol inhibitory action, but not in mediation of the AVP response to physical exercise.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19649691     DOI: 10.1007/s00702-009-0270-5

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  14 in total

Review 1.  Endogenous opioid peptides: a guide to structures and terminology.

Authors:  B M Cox
Journal:  Life Sci       Date:  1982 Oct 18-25       Impact factor: 5.037

2.  Plasma volume, osmolality, vasopressin, and renin activity during graded exercise in man.

Authors:  V A Convertino; L C Keil; E M Bernauer; J E Greenleaf
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1981-01

3.  Naloxone increases the angiotensin II stimulated rise of arginine vasopressin and oxytocin secretion in man.

Authors:  V Coiro; P Chiodera
Journal:  Neuroendocrinology       Date:  1991-03       Impact factor: 4.914

4.  Metergoline, naloxone, and sodium valproate did not modify arginine vasopressin response to insulin-induced hypoglycemia in man.

Authors:  P Chiodera; A Gnudi; R Volpi; L d'Amato; C Marchesi; G Pioli; P Muzzetto; A Castelli; L Bianconi; R Minelli
Journal:  J Endocrinol Invest       Date:  1988-05       Impact factor: 4.256

5.  Neuroendocrine effects of endogenous opioid peptides in human subjects: a review.

Authors:  J E Morley
Journal:  Psychoneuroendocrinology       Date:  1983       Impact factor: 4.905

6.  Effects of the opiate antagonist naloxone and the enkephalin analog DAMME on the vasopressin response to a hypertonic stimulus in man.

Authors:  S L Lightman; N Langdon; M L Forsling
Journal:  J Clin Endocrinol Metab       Date:  1980-12       Impact factor: 5.958

7.  Naloxone increases the nicotine-stimulated rise of vasopressin secretion in man.

Authors:  S Lightman; N Langdon; K Todd; M Forsling
Journal:  Clin Endocrinol (Oxf)       Date:  1982-04       Impact factor: 3.478

8.  Plasma renin activity, vasopressin concentration, and urinary excretory responses to exercise in men.

Authors:  C E Wade; J R Claybaugh
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1980-12

9.  Naloxone decreases the inhibiting effect of ethanol on the release of arginine-vasopressin induced by cigarette smoking in man.

Authors:  P Chiodera; L d'Amato; C Davoli; R Volpi; R Delsignore; A Gnudi; V Coiro
Journal:  Metabolism       Date:  1987-08       Impact factor: 8.694

10.  Plasma AVP, neurophysin, renin activity, and aldosterone during submaximal exercise performed until exhaustion in trained and untrained men.

Authors:  B Melin; J P Eclache; G Geelen; G Annat; A M Allevard; E Jarsaillon; A Zebidi; J J Legros; C Gharib
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1980
View more
  1 in total

Review 1.  Tobacco Use and Periodontal Disease-The Role of Microvascular Dysfunction.

Authors:  Henrique Silva
Journal:  Biology (Basel)       Date:  2021-05-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.